UNSPSC 51334307: Chlorprothixene acetate

This classification denotes an antipsychotic agent C18H19ClNS.C2H3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K45X4JP9Q1, chemically known as 1-propanamine, 3-(2-chloro-9h-thioxanthen-9-ylidene)-n,n-dimethyl-, (z)-, acetate, but more generally known as chlorprothixene acetate, which bears US NIH Compound Identifier 24892861. European Medicines Agency schedules Chlorprothixene acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35546.

Most nations, for tariff and trade purposes, schedule chlorprothixene acetate under HS 29349910 and SITC 51579. As of Q4 2014, CHLORPROTHIXENE ACETATE remains US FDA's Preferred Term for this commodity. SMILES: CC(=O)[O-].C[NH+](C)CC/C=C\1/C2CCCCC2SC3C1CC(CC3)CL.

UNSPSC 51334307 Chlorprothixene acetate is a Commodity code for a specific pharmaceutical compound, but recent state and local procurement activity under this code does not reflect purchases of chlorprothixene acetate itself. Instead, Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 for naloxone and safe drug deactivation systems — a substantial mismatch between the code's nominal scope and actual procurement need. The code appears to see limited relevant state and local activity; the single recent opportunity on file targets opioid-response commodities rather than the antipsychotic agent the code name specifies.

Seminole County's IFB 60459723LAS, due July 26, 2026 (updated from an earlier July 2023 posting date in the source), seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The contract runs two years with a one-year renewal option, fixed-fee pricing, and requirements for workers' compensation, commercial general liability, and professional liability insurance. E-Verify compliance and drug-free workplace certification are mandatory; potential FEMA funding introduces federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations are noted. The narrow activity under this code and the disconnect between the code classification and the actual procurement suggest either a data-entry error or dormant category status — business development professionals should verify the correct UNSPSC code for naloxone and drug deactivation products before pursuing this opportunity.